All Stories

  1. The paper by Hsiao use the primers that not specific for the NEMO gene

    Article • Journal of the Formosan Medical Association, October 2018, Elsevier

    Dayong Si

  2. Association of Common Polymorphisms in β1-adrenergic Receptor With Antihypertensive Response to Carvedilol

    Article • Journal of Cardiovascular Pharmacology, October 2014, Wolters Kluwer Health

    Dayong Si

  3. Whole exome sequencing identifies a novel EMDmutation in a Chinese family with dilated cardiomyopathy

    Article • BMC Medical Genetics, July 2014, Springer Science + Business Media

    Dayong Si

  4. Distribution of CYP2C9*13 allele in the Chinese Han and the long‐range haplotype containing CYP2C9*13 and CYP2C19*2

    Article • Biopharmaceutics & Drug Disposition, September 2012, Wiley

    Dayong Si

  5. Two NovelSCN9AGene Heterozygous Mutations May Cause Partial Deletion of Pain Perception

    Article • Pain Medicine, October 2011, Oxford University Press (OUP)

    Dayong Si

  6. Genetic characteristics and migration history of a bronze culture population in the West Liao-River valley revealed by ancient DNA

    Article • Journal of Human Genetics, September 2011, Springer Science + Business Media

    Dayong Si

  7. Mechanism of CYP2C9 Inhibition by Flavones and Flavonols

    Article • Drug Metabolism and Disposition, December 2008, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dayong Si

  8. Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects

    Article • British Journal of Clinical Pharmacology, July 2007, Wiley

    Dayong Si

  9. ROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANS

    Article • Drug Metabolism and Disposition, March 2005, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dayong Si

  10. Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype

    Article • British Journal of Clinical Pharmacology, January 2005, Wiley

    Dayong Si

  11. First identification of novel variant CYP2C9*13 in Chinese

    Article • Pharmacogenetics, July 2004, Wolters Kluwer Health

    Dayong Si